Showing results (351-360 of 513) with videos related to
Sort By:
Pageof 52
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2024
The Risk and Reversibility of Osimertinib-Related Cardiotoxicity in a Real-World PopulationMinjung Bak, Hyukjin Park, Se-Hoon Lee, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung CancerHaa-Na Song, Ki Sun Jung, Kwai Han Yoo, et al.Lung Cancer (Amsterdam, Netherlands)|November 7, 2025
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS studyHyun Ae Jung, Tae Min Kim, Hye Ryun Kim, et al.Cancer Chemotherapy and Pharmacology|August 10, 2005
Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancerSe Hoon Park, Jeeyun Lee, Se Hoon Lee, et al.Journal of Breast Cancer|April 18, 2013
Efficacy of exemestane in korean patients with metastatic breast cancer after failure of nonsteroidal aromatase inhibitorsJune Koo Lee, Seock-Ah Im, Daewon Lee, et al.Journal of Korean Medical Science|February 2, 2017
Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokersHa Youn Lee, Se Hoon Lee, Jae Kyung Won, et al.Thrombosis and Haemostasis|January 31, 2014
Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancerYun-Gyoo Lee, Inho Kim, Eunyoung Lee, et al.Breast Cancer Research : BCR|March 4, 2011
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosisBhumsuk Keam, Seock-Ah Im, Kyung-Hun Lee, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2017
Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung CancerJong-Mu Sun, Jae Myung Noh, Dongryul Oh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)Hyun Ae Jung, Miso Kim, Hae Su Kim, et al.Pageof 52